Marshall Wace »

Hemab Therapeutics Holdings shares owned by Marshall Wace

Quarter-by-quarter ownership of Hemab Therapeutics Holdings shares owned by Marshall Wace from 13F filings

Historical chart of Marshall Wace investment in Hemab Therapeutics Holdings

Tip: Access up to 7 years of quarterly data

All positions including Hemab Therapeutics Holdings held by Marshall Wace consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Hemab Therapeutics Holdings by Marshall Wace

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.7M 155k 36.73

More positions owned by Marshall Wace

Ishares-s&p 500 Equity Option Call Option (IVV)
Spdr Portfolio L Etp (SPYM)
Apple Common Stock (AAPL)
Adv Micro Device Common Stock (AMD)
Amazon.com Common Stock (AMZN)
Nvidia Corp Common Stock (NVDA)
Micron Tech Common Stock (MU)
Microsoft Corp Common Stock (MSFT)
Costco Wholesale Common Stock (COST)
Taiwan Semic- Adr (TSM)
Morgan Stanley Common Stock (MS)
Tesla Common Stock (TSLA)
Unitedhealth Grp Common Stock (UNH)
Alphabet Inc-a Common Stock (GOOGL)
Hilton Worldwide Common Stock (HLT)

View all positions for Marshall Wace

Top funds holding Hemab Therapeutics Holdings

RA Capital Management
Novo A/S
Jpmorgan Chase & Co
Vanguard Capital Management
Citadel Advisors
Braidwell
Marshall Wace
Affinity Asset Advisors
Vanguard Fiduciary Trust
Burkehill Global Management
Standard Life Aberdeen
TD Asset Management
GSA Capital Partners
Schonfeld Strategic Advisors
Vanguard Portfolio Management

View all funds holding Hemab Therapeutics Holdings